Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 4.3 Master Services Agreement
- 4.5 Cooperation Agreement
- 4.10 Global Employee Share Option Plan
- 4.14 Employment Agreement Between Prima Biomed and Sharron Gargosky
- 4.15 Employment Agreement Between Prima Biomed and Marc Voigt
- 12.1 Certification of Chief Executive Officer As Required by Rule 13A-14(A)
- 12.2 Certification of Chief Financial Officer As Required by Rule 13A-14(A)
- 13.1 Certification of Chief Executive Officer As Required by Rule 13A-14(B)
- 13.2 Certification of Chief Financial Officer As Required by Rule 13A-14(B)
- 16.1 Letter Regarding Change In Certifying Accountant
IMMP similar filings
Filing view
External links
Exhibit 16.1
REF: | KPA:BPL:PRIM5601 |
September 27, 2012
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington D.C. 20549
Ladies and Gentlemen:
We have read the statements made by Prima BioMed Ltd set forth in Item 16F of the annual report on Form 20-F as filed with the Securities and Exchange Commission.
We agree with the statements concerning our Firm in such Form 20-F.
Yours sincerely
KEVIN P ADAMS
Director
MDHC Audit Assurance Pty Ltd